+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
From
BREYANZI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

BREYANZI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
MONJUVI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

MONJUVI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
ZYNLONTA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ZYNLONTA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
POLIVY Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

POLIVY Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
EPKINLY Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EPKINLY Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
From
From
DELYTACT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

DELYTACT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
Triple Negative Breast Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Triple Negative Breast Cancer - Epidemiology Forecast - 2032

  • Report
  • September 2023
  • 112 Pages
  • Global
From
From
From
From
United States PIQRAY Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States PIQRAY Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022 - Product Thumbnail Image

Waldenstrom's Macroglobulinaemia - Pipeline Insight, 2022

  • Clinical Trials
  • November 2022
  • 80 Pages
  • Global
From
Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cholangiocarcinoma (CCA) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 162 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more